GANX
Price
$1.75
Change
-$0.01 (-0.57%)
Updated
Sep 8, 04:59 PM (EDT)
Capitalization
63.27M
60 days until earnings call
TRDA
Price
$5.26
Change
-$0.03 (-0.57%)
Updated
Sep 8, 04:59 PM (EDT)
Capitalization
201.22M
64 days until earnings call
Interact to see
Advertisement

GANX vs TRDA

Header iconGANX vs TRDA Comparison
Open Charts GANX vs TRDABanner chart's image
Gain Therapeutics
Price$1.75
Change-$0.01 (-0.57%)
Volume$646
Capitalization63.27M
Entrada Therapeutics
Price$5.26
Change-$0.03 (-0.57%)
Volume$20.54K
Capitalization201.22M
GANX vs TRDA Comparison Chart in %
Loading...
GANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GANX vs. TRDA commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GANX is a Hold and TRDA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (GANX: $1.76 vs. TRDA: $5.29)
Brand notoriety: GANX and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GANX: 133% vs. TRDA: 165%
Market capitalization -- GANX: $63.27M vs. TRDA: $201.22M
GANX [@Biotechnology] is valued at $63.27M. TRDA’s [@Biotechnology] market capitalization is $201.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GANX’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • GANX’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, both GANX and TRDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GANX’s TA Score shows that 4 TA indicator(s) are bullish while TRDA’s TA Score has 5 bullish TA indicator(s).

  • GANX’s TA Score: 4 bullish, 6 bearish.
  • TRDA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, TRDA is a better buy in the short-term than GANX.

Price Growth

GANX (@Biotechnology) experienced а -11.56% price change this week, while TRDA (@Biotechnology) price change was -3.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.13%. For the same industry, the average monthly price growth was +10.99%, and the average quarterly price growth was +33.00%.

Reported Earning Dates

GANX is expected to report earnings on Nov 07, 2025.

TRDA is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRDA($201M) has a higher market cap than GANX($63.3M). GANX YTD gains are higher at: -18.519 vs. TRDA (-69.404). GANX has higher annual earnings (EBITDA): -17.16M vs. TRDA (-92.26M). TRDA has more cash in the bank: 354M vs. GANX (6.69M). GANX has less debt than TRDA: GANX (681K) vs TRDA (54.7M). TRDA has higher revenues than GANX: TRDA (79.5M) vs GANX (0).
GANXTRDAGANX / TRDA
Capitalization63.3M201M31%
EBITDA-17.16M-92.26M19%
Gain YTD-18.519-69.40427%
P/E RatioN/A10.05-
Revenue079.5M-
Total Cash6.69M354M2%
Total Debt681K54.7M1%
TECHNICAL ANALYSIS
Technical Analysis
GANXTRDA
RSI
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 18 days ago
84%
Declines
ODDS (%)
Bearish Trend 29 days ago
90%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
81%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPFX1.700.26
+18.06%
Standard Premium Finance Holdings, Inc.
SRRPF5.25N/A
N/A
Shagrir Group Veh Svcs Ltd
BKGFF49.16N/A
N/A
Berkeley Group Holdings Plc.
HNSPF4.58N/A
N/A
Hansoh Pharmaceutical Group Co Ltd.
KRNGY2.28N/A
N/A
KAROON ENERGY LTD.

GANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GANX has been loosely correlated with COYA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GANX jumps, then COYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GANX
1D Price
Change %
GANX100%
+1.15%
COYA - GANX
37%
Loosely correlated
-1.72%
TRDA - GANX
34%
Loosely correlated
+1.34%
EYPT - GANX
33%
Loosely correlated
+17.93%
ELVN - GANX
33%
Loosely correlated
+0.70%
MGTX - GANX
32%
Poorly correlated
-0.39%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with CRNX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+1.34%
CRNX - TRDA
52%
Loosely correlated
+3.97%
SYRE - TRDA
51%
Loosely correlated
+0.06%
XNCR - TRDA
51%
Loosely correlated
+2.15%
IDYA - TRDA
50%
Loosely correlated
+5.15%
DYN - TRDA
49%
Loosely correlated
+7.40%
More